Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new results and criteria for a clinical study involving pembrolizumab and trastuzumab for HER2 positive gastric cancer, with specific details on treatment protocols and efficacy measures. The results reporting dates have also been updated.
    Difference
    14%
    Check dated 2025-03-20T10:43:21.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now indicates that results have been submitted, replacing the previous message that no results were posted.
    Difference
    0.1%
    Check dated 2025-03-06T01:16:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-26T20:01:50.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.6%
    Check dated 2025-02-11T07:28:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-04T02:44:05.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-20T19:29:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.